7.30
price down icon0.54%   -0.04
after-market Dopo l'orario di chiusura: 7.56 0.26 +3.56%
loading
Precedente Chiudi:
$7.34
Aprire:
$7.46
Volume 24 ore:
216.83K
Relative Volume:
0.82
Capitalizzazione di mercato:
$153.49M
Reddito:
-
Utile/perdita netta:
$-52.07M
Rapporto P/E:
-35.15
EPS:
-0.2077
Flusso di cassa netto:
$-44.93M
1 W Prestazione:
-2.14%
1M Prestazione:
-22.91%
6M Prestazione:
-3.95%
1 anno Prestazione:
-54.26%
Intervallo 1D:
Value
$7.20
$7.64
Intervallo di 1 settimana:
Value
$7.00
$7.64
Portata 52W:
Value
$6.50
$18.05

Cybin Inc Stock (CYBN) Company Profile

Name
Nome
Cybin Inc
Name
Telefono
908 764 8385
Name
Indirizzo
100 King Street West, Suite 5600, Toronto
Name
Dipendente
38
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
CYBN's Discussions on Twitter

Confronta CYBN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CYBN
Cybin Inc
7.30 153.49M 0 -52.07M -44.93M -0.2077
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
502.92 129.14B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
680.61 74.41B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
581.21 35.31B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
241.75 31.30B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
254.57 27.35B 3.32B -860.46M -1.04B -8.32

Cybin Inc Stock (CYBN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-11-19 Downgrade Maxim Group Buy → Hold

Cybin Inc Borsa (CYBN) Ultime notizie

pulisher
Mar 13, 2025

Cybin stock wins new Buy from Guggenheim (CYBN:NYSE) - Seeking Alpha

Mar 13, 2025
pulisher
Mar 13, 2025

Cybin wins new Buy from Guggenheim: potential to challenge J&J’s Spravato cited - MSN

Mar 13, 2025
pulisher
Mar 12, 2025

Cybin initiated with a Buy at Guggenheim - TipRanks

Mar 12, 2025
pulisher
Mar 11, 2025

Cybin Inc. Reports Q3 2025 Financial Results and Strategic Progress - TipRanks

Mar 11, 2025
pulisher
Mar 07, 2025

Psychedelic Science 2025 Announces Select Speakers for the Leading Conference on Psychedelic Research, Policy, and Thought Leadership - GlobeNewswire Inc.

Mar 07, 2025
pulisher
Mar 04, 2025

Cybin Inc. (CYBN) Loses -25.81% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Nasdaq

Mar 04, 2025
pulisher
Mar 01, 2025

Cybin Inc. (CYBN): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Mar 01, 2025
pulisher
Feb 23, 2025

Wall Street Analysts Think Cybin Inc. (CYBN) Could Surge 988.67%: Read This Before Placing a Bet - MSN

Feb 23, 2025
pulisher
Feb 23, 2025

Cybin (OTCMKTS:CLXPF) Shares Down 2.5%Here's What Happened - MarketBeat

Feb 23, 2025
pulisher
Feb 23, 2025

How to Take Advantage of moves in (CYBN) - Stock Traders Daily

Feb 23, 2025
pulisher
Feb 20, 2025

Revolutionizing Mental Health Through Psychedelic Therapeutics | by Dr. Gleb Tsipursky | Feb, 2025 - DataDrivenInvestor

Feb 20, 2025
pulisher
Feb 18, 2025

Cybin (NYSE:CYBN) Price Target Cut to $150.00 by Analysts at HC Wainwright - MarketBeat

Feb 18, 2025
pulisher
Feb 16, 2025

Cybin (OTCMKTS:CYBN) Trading Up 1.2%Here's Why - MarketBeat

Feb 16, 2025
pulisher
Feb 16, 2025

Canaccord cuts Cybin stock target to $73, maintains Buy rating - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

Cybin (NYSE:CYBN) Price Target Lowered to $73.00 at Canaccord Genuity Group - MarketBeat

Feb 16, 2025
pulisher
Feb 14, 2025

Cybin stock price target cut to $150 at H.C. Wainwright - MSN

Feb 14, 2025
pulisher
Feb 13, 2025

Cybin stock price target cut to $150 at H.C. Wainwright By Investing.com - Investing.com Australia

Feb 13, 2025
pulisher
Feb 12, 2025

Canaccord cuts Cybin stock target to $73, maintains Buy rating By Investing.com - Investing.com Nigeria

Feb 12, 2025
pulisher
Feb 12, 2025

(CYBN) Investment Analysis - Stock Traders Daily

Feb 12, 2025
pulisher
Feb 11, 2025

Cybin sees third-quarter loss on R&D costs, advances clinical programs - Green Market Report

Feb 11, 2025
pulisher
Feb 10, 2025

Cybin Accelerates PARADIGM Program for Depression Treatment - TipRanks

Feb 10, 2025
pulisher
Feb 10, 2025

Cybin's Depression Drug Shows Perfect Response Rate, Advances to Pivotal Phase 3 with C$136M War Chest - StockTitan

Feb 10, 2025
pulisher
Feb 10, 2025

Upstart (UPST) Reports Earnings Tomorrow: What To Expect - The Globe and Mail

Feb 10, 2025
pulisher
Feb 10, 2025

Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights - Business Wire

Feb 10, 2025
pulisher
Feb 10, 2025

About Us - Financial Content

Feb 10, 2025
pulisher
Feb 07, 2025

Trade thoughts for Gold futures - The Globe and Mail

Feb 07, 2025
pulisher
Feb 07, 2025

Is Rigetti Computing a Millionaire-Maker Stock? - The Globe and Mail

Feb 07, 2025
pulisher
Feb 03, 2025

HC Wainwright Forecasts Cybin's Q3 Earnings (NYSE:CYBN) - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

What is HC Wainwright's Estimate for Cybin FY2029 Earnings? - MarketBeat

Feb 03, 2025
pulisher
Feb 02, 2025

Cybin (OTCMKTS:CLXPF) Shares Up 1.9%What's Next? - MarketBeat

Feb 02, 2025
pulisher
Feb 01, 2025

What is HC Wainwright's Forecast for Cybin FY2029 Earnings? - MarketBeat

Feb 01, 2025
pulisher
Jan 31, 2025

How To Trade (CYBN) - Stock Traders Daily

Jan 31, 2025
pulisher
Jan 31, 2025

HC Wainwright Issues Optimistic Estimate for Cybin Earnings - Defense World

Jan 31, 2025
pulisher
Jan 30, 2025

Wall Street Analysts Believe Cybin Inc. (CYBN) Could Rally 952.23%: Here's is How to Trade - Yahoo Finance

Jan 30, 2025
pulisher
Jan 30, 2025

HC Wainwright Has Bearish Outlook for Cybin FY2029 Earnings - Defense World

Jan 30, 2025
pulisher
Jan 29, 2025

H.C. Wainwright maintains $190 target on Cybin Inc. shares - MSN

Jan 29, 2025

Cybin Inc Azioni (CYBN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Capitalizzazione:     |  Volume (24 ore):